Literature DB >> 11720464

Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma.

E A Engels1, P S Rosenberg, M Frisch, J J Goedert.   

Abstract

Kaposi's sarcoma (KS), common among persons with acquired immunodeficiency syndrome (AIDS), is caused by KS herpesvirus (KSHV) but whether KSHV causes other malignancies is uncertain. Using linked United States AIDS and cancer registries, we measured the incidence of specific malignancies in persons with AIDS (4-27 months after AIDS onset). We identified associations with KSHV by calculating a relative risk: cancer incidence in persons with KS (all were KSHV-infected) divided by incidence in persons without KS. Using Poisson regression, relative risks were adjusted for human immunodeficiency virus risk group, gender, age, race, and calendar year. We included 189 159 subjects (26 972 with KS). Immunoblastic lymphoma was significantly associated with KS (506 cases; relative risks: unadjusted 2.44, 95%CI 2.00-2.96, adjusted 1.58, 95%CI 1.29-1.93). Only one immunoblastic lymphoma had pleura as primary site. None of 37 other specified malignancies (other non-Hodgkin lymphomas, haematological malignancies, solid tumours) was significantly associated with KS. In summary, the association of immunoblastic lymphoma with KS was specific among examined malignancies and remained significant after statistical adjustment. Our findings, and the previously demonstrated presence of KSHV in the histologically related primary effusion lymphoma, suggest that KSHV is involved in the pathogenesis of some immunoblastic lymphomas. Copyright 2001 Cancer Research Campaign

Entities:  

Mesh:

Year:  2001        PMID: 11720464      PMCID: PMC2375238          DOI: 10.1054/bjoc.2001.2052

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Antibodies against human herpesvirus 8 in black South African patients with cancer.

Authors:  F Sitas; H Carrara; V Beral; R Newton; G Reeves; D Bull; U Jentsch; R Pacella-Norman; D Bourboulia; D Whitby; C Boshoff; R Weiss
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

Review 2.  Kaposi's sarcoma.

Authors:  K Antman; Y Chang
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

Review 3.  HHV-8 is present in multiple myeloma patients.

Authors:  J R Berenson; R A Vescio
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

Review 4.  Kaposi's sarcoma-associated herpesvirus and multiple myeloma: lack of criteria for causality.

Authors:  K Tarte; Y Chang; B Klein
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

5.  Identifying human herpesvirus 8 infection: performance characteristics of serologic assays.

Authors:  E A Engels; D Whitby; P B Goebel; A Stossel; D Waters; A Pintus; L Contu; R J Biggar; J J Goedert
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-01       Impact factor: 3.731

6.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.

Authors:  N Dupin; T L Diss; P Kellam; M Tulliez; M Q Du; D Sicard; R A Weiss; P G Isaacson; C Boshoff
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

Review 7.  The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.

Authors:  E Cesarman; D M Knowles
Journal:  Semin Cancer Biol       Date:  1999-06       Impact factor: 15.707

8.  Sexual transmission and the natural history of human herpesvirus 8 infection.

Authors:  J N Martin; D E Ganem; D H Osmond; K A Page-Shafer; D Macrae; D H Kedes
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

9.  Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.

Authors:  M Melbye; P M Cook; H Hjalgrim; K Begtrup; G R Simpson; R J Biggar; P Ebbesen; T F Schulz
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

10.  Sexual behaviour, STDs and risks for prostate cancer.

Authors:  R B Hayes; L M Pottern; H Strickler; C Rabkin; V Pope; G M Swanson; R S Greenberg; J B Schoenberg; J Liff; A G Schwartz; R N Hoover; J F Fraumeni
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more
  6 in total

1.  Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk.

Authors:  Daniel C Beachler; Lan L Gellert; Lisa P Jacobson; Richard F Ambinder; Elizabeth C Breen; Otoniel Martínez-Maza; Charles S Rabkin; Charles C Rabkin; Richard A Kaslow; Gypsyamber D'Souza
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

Review 2.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

Review 3.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

4.  Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.

Authors:  Julia Bohlius; Kurt Schmidlin; Dominique Costagliola; Gerd Fätkenheuer; Margaret May; Anna Maria Caro-Murillo; Amanda Mocroft; Fabrice Bonnet; Gary Clifford; Anastasia Karafoulidou; Jose M Miro; Jens Lundgren; Genevieve Chene; Matthias Egger
Journal:  Antivir Ther       Date:  2009

5.  Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Gordana Halec; Tim Waterboer; Nicole Brenner; Julia Butt; W David Hardy; Gypsyamber DʼSouza; Steven Wolinsky; Bernard J Macatangay; Michael Pawlita; Roger Detels; Otoniel Martínez-Maza; Shehnaz K Hussain
Journal:  J Acquir Immune Defic Syndr       Date:  2019-03-01       Impact factor: 3.771

6.  Aggressive recurrent orbital rhabdomyosarcoma in adulthood.

Authors:  Tagrid Y Ahmad; Hasan N Al Houri; Abdullah N Al Houri; Nagham Y Ahmad
Journal:  Avicenna J Med       Date:  2019 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.